DC
TDOC icon

Davenport & Co’s Teladoc Health TDOC Stock Holding History

Davenport & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,848
Closed -$234K – 1114
2021
Q3 		$234K Buy
1,848
+340
+23% +$49.5K ﹤0.01% 934
2021
Q2 		$251K Buy
+1,508
New +$244K ﹤0.01% 851

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Davenport & Co's TDOC Position: Q4 2021 in Review

Davenport & Co sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,848 shares — an estimated $234K sold.

Davenport & Co first reported a position in TDOC in Q2 2021 and held it in 2 quarters. The position peaked at $251K in Q2 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Davenport & Co reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Davenport & Co sold 1,848 Teladoc Health shares in Q4 2021, an estimated $234K.
  • Davenport & Co first reported a position in Teladoc Health in Q2 2021 and held it in 2 quarters.
  • Davenport & Co's Teladoc Health position peaked at $251K in Q2 2021.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Davenport & Co's 13F filing for Q4 2021, filed 10 Feb 2022.